Contents

Current Medicinal Chemistry, Volume 14 - Number 23

The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease

, 14(23): 2421 - 2428

Francesco Fornai, Riccardo Ruffoli, Paola Soldani, Stefano Ruggieri and Antonio Paparelli


DOI: 10.2174/092986707782023631




P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain

, 14(23): 2429 - 2455

W. Fischer and U. Krugel


DOI: 10.2174/092986707782023695




The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies

, 14(23): 2456 - 2470

Marjelo Mines, Yun Ding and Guo-Huang Fan


DOI: 10.2174/092986707782023686




The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development

, 14(23): 2471 - 2481

Kevin R. Guertin and Yong-Mi Choi


DOI: 10.2174/092986707782023659




Tight Junction Modulators: Promising Candidates for Drug Delivery

, 14(23): 2482 - 2488

M. Kondoh and K. Yagi


DOI: 10.2174/092986707782023640




Onconeural Versus Paraneoplastic Antigens?

, 14(23): 2489 - 2494

S. B. Eichmuller and A. V. Bazhin


DOI: 10.2174/092986707782023668




Antiangiogenic Agents: an Update on Small Molecule VEGFR Inhibitors

, 14(23): 2495 - 2516

S. Schenone, F. Bondavalli and M. Botta


DOI: 10.2174/092986707782023622




The DDX3 Subfamily of the DEAD Box Helicases: Divergent Roles as Unveiled by Studying Different Organisms and In Vitro Assays

, 14(23): 2517 - 2525

A. Rosner and B. Rinkevich


DOI: 10.2174/092986707782023677




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science